Boom Capital Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
BioLoomicsbioloomics.cominSep 2023 · $8.7M
Boulder-based preclinical biotech using human-cell directed evolution to create target-degrading antibodies and next-generation ADCs.
Boulder, US
Doug Chapnick(Founder)in
BoardJoel Dudley(Director)inNicholas Saccomano(Director)
Co-investorsHorizons VenturesBoxOne VenturesInnovation EndeavorsTechU Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.